• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伏格特-小柳-原田病:治疗与视力预后

Vogt Koyanagi Harada disease: treatment and visual prognosis.

作者信息

Alam Mumtaz, Iqbal Mustafa, Khan Bakht Samar, Hussain Ibrar

机构信息

Department of Ophthalmology, Eye 'B' Unit, Khyber Teaching Hospital, Peshawar.

出版信息

J Coll Physicians Surg Pak. 2013 Oct;23(10):740-2. doi: 10.2013/JCPSP.740742.

DOI:10.2013/JCPSP.740742
PMID:24112262
Abstract

Vogt Koyanagi Harada (VKH) disease is a chronic, bilateral, granulomatous panuveitis associated with central nervous system, auditory and integumentary manifestations. The study was conducted from January 2001 to December 2010 at the Department of Ophthalmology, Khyber Teaching Hospital, Peshawar. A total of 9 patients with diagnosis of Vogt Koyanagi Harada disease were included in the study. Extracted data included age, gender, duration of disease, initial and final visual acuities, treatment and complications. Initial visual acuity was ranging from 6/24 to perception of light. All the patients were treated with systemic and topical corticosteroids. In addition, one patient also received cytotoxic therapy. Final visual acuity was 6/18 or better in all cases (100%). One patient developed bilateral cataract, glaucoma and subretinal fibrosis at the macula. The cataract and glaucoma were managed as per established protocols. The visual prognosis of Vogt Koyanagi Harada disease is generally favourable if the disease is identified early and adequately treated and the associated complications are addressed properly.

摘要

伏格特-小柳-原田(VKH)病是一种慢性、双侧性、肉芽肿性全葡萄膜炎,伴有中枢神经系统、听觉及皮肤表现。该研究于2001年1月至2010年12月在白沙瓦开伯尔教学医院眼科进行。共有9例诊断为伏格特-小柳-原田病的患者纳入该研究。提取的数据包括年龄、性别、病程、初始及最终视力、治疗及并发症。初始视力范围为6/24至光感。所有患者均接受全身及局部皮质类固醇治疗。此外,1例患者还接受了细胞毒性疗法。所有病例(100%)的最终视力均为6/18或更好。1例患者出现双侧白内障、青光眼及黄斑部视网膜下纤维化。白内障和青光眼按照既定方案进行处理。如果能早期识别并充分治疗伏格特-小柳-原田病,并妥善处理相关并发症,其视觉预后通常较好。

相似文献

1
Vogt Koyanagi Harada disease: treatment and visual prognosis.伏格特-小柳-原田病:治疗与视力预后
J Coll Physicians Surg Pak. 2013 Oct;23(10):740-2. doi: 10.2013/JCPSP.740742.
2
Vogt-Koyanagi-Harada disease in children.儿童伏格特-小柳-原田病
Eye (Lond). 2008 Sep;22(9):1124-31. doi: 10.1038/sj.eye.6702859. Epub 2007 May 4.
3
Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.印度南部 Vogt-Koyanagi-Harada 病患儿的患病率、临床特征和致盲原因。
Retina. 2010 Jul-Aug;30(7):1113-21. doi: 10.1097/IAE.0b013e3181c96a87.
4
Vogt-koyanagi-harada syndrome.伏格特-小柳-原田综合征
Curr Eye Res. 2008 Jul;33(7):517-23. doi: 10.1080/02713680802233968.
5
[Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease].[Vogt-小柳-原田病的诊断与治疗进展及存在的问题]
Zhonghua Yan Ke Za Zhi. 2012 Jun;48(6):572-6.
6
Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.霉酚酸酯联合全身用糖皮质激素可预防与Vogt-小柳-原田病相关的初发性急性葡萄膜炎进展为慢性复发性炎症和“晚霞眼底”的形成。
Acta Ophthalmol. 2017 Feb;95(1):85-90. doi: 10.1111/aos.13189. Epub 2016 Aug 18.
7
[Vogt-Koyanagi-Harada disease].[伏格特-小柳-原田病]
Tidsskr Nor Laegeforen. 2005 Aug 25;125(16):2195-7.
8
Prognostic factors for Vogt-Koyanagi-Harada disease.伏格特-小柳-原田病的预后因素
J Chin Med Assoc. 2003 Mar;66(3):148-54.
9
Complications and prognostic factors in Vogt-Koyanagi-Harada disease.Vogt-小柳-原田病的并发症及预后因素
Am J Ophthalmol. 2001 May;131(5):599-606. doi: 10.1016/s0002-9394(01)00937-0.
10
Prognostic factors in Vogt-Koyanagi-Harada disease.伏格特-小柳-原田病的预后因素
Int Ophthalmol. 2007 Apr-Jun;27(2-3):201-10. doi: 10.1007/s10792-007-9062-9. Epub 2007 Apr 14.

引用本文的文献

1
[Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].[自体荧光联合光谱域光学相干断层扫描用于急性Vogt-小柳-原田病的诊断及随访]
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jan 30;41(1):135-140. doi: 10.12122/j.issn.1673-4254.2021.01.20.
2
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.利妥昔单抗治疗伏格特-小柳-原田病后持久的葡萄膜炎缓解及听力丧失恢复
Clin Rheumatol. 2015 Oct;34(10):1817-20. doi: 10.1007/s10067-014-2781-1. Epub 2014 Sep 16.
3
Gender differences in vogt-koyanagi-harada disease and sympathetic ophthalmia.
交感性眼炎与Vogt-小柳原田病的性别差异。
J Ophthalmol. 2014;2014:157803. doi: 10.1155/2014/157803. Epub 2014 Mar 5.